The 11th Drug Hypersensitivity Meeting (DHM) will be taking place in Antwerp, Belgium on 9-11th April 2026. The title of the DHM 2026 meeting “Bridging basic and clinical science in drug hypersensitivity”, integrates basic and clinical science in each session.

The scientific programme covers a wide range of topics including challengesof current paradigms, emerging mechanisms, advances in diagnosis and treatment, management of drug allergy in pediatrics and immunologically vulnerable patients, and the importance of interdisciplinary collaboration. Sessions include plenary lectures, parallel symposia, pro-con debate sessions and junior member educational activities on both immediate and delayed hypersensitivity.

Registration is now open, with early registration up till 19th January 2026.

Abstracts submission deadline: 8th January 2026.

For further information visit the website: DHM 2026